ICCM - FDA agrees to review IceCure request for De Novo classification
2024-01-30 17:23:08 ET
More on IceCure Medical
- IceCure Medical Ltd (ICCM) Q3 2023 Earnings Call Transcript
- IceCure shares rally 53% on ProSense kidney cancer study
- IceCure stock climbs 10% amid FDA appeal, earnings report
- Seeking Alpha’s Quant Rating on IceCure Medical
- Historical earnings data for IceCure Medical